Devendra K Hiwase

25PUBLICATIONS
156CO-AUTHORS
Gene and molecular therapyHaematological tumoursCardiovascular medicine and haematology not elsewhere classifiedPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jun 29, 2026
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database.

|Apr 23, 2026
Pre-transplant azacitidine does not improve survival in allogeneic HSCT for higher-risk MDS.

|Apr 01, 2026
Defining remission and relapse after allogeneic hematopoietic cell transplantation in myelodysplastic/myeloproliferative neoplasms and optimization of transplantation outcomes: Recommendations from the EBMT practice harmonisation and guidelines committee.

Christopher Armstrong, Kavita Raj, Giorgia Battipaglia

|May 22, 2025
RAS mutation identifies a poor prognostic molecular subtype of therapy-related myeloid neoplasm.

Chung Hoow Kok, Aref Al-Kali, Daniel Thomas

|May 13, 2025
Clinical response to azacitidine in MDS is associated with distinct DNA methylation changes in HSPCs.

Julie A I Thoms, Feng Yan, Henry R Hampton

|May 07, 2025
Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort.

Mithun Vinod Shah, Kevin Hung, Anmol Baranwal

Pageof 5

Frequent Collaborators

15 joint publications

Mithun Vinod Shah

9 joint publications

Naseema Gangat

9 joint publications

Mrinal Patnaik

8 joint publications

Chung Hoow Kok